Literature DB >> 12188489

Stage-IIB osteosarcomas around the knee. A study of MMP-9 in surviving tumour cells.

A F Foukas1, N S Deshmukh, R J Grimer, D C Mangham, E G Mangos, S Taylor.   

Abstract

We studied 55 patients with stage-IIB osteosarcoma around the knee with respect to the expression of matrix metalloproteinase (MMP)-9 in the surviving tumour cells in surgical resection specimens. They were followed up for a minimum of 2.5 years. Factors significantly associated with poor overall survival were a high serum level of alkaline phosphatase at diagnosis and tumour cells expressing MMP-9 in the resection specimens. The only factor strongly associated with disease-free survival was the immunohistochemical status of tumour cells for MMP-9 in the resection specimens. The percentage of necrosis after chemotherapy failed marginally to reach statistical significance. On Cox regression analysis only MMP-9 remained significant for overall and disease-free survival.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12188489     DOI: 10.1302/0301-620x.84b5.12512

Source DB:  PubMed          Journal:  J Bone Joint Surg Br        ISSN: 0301-620X


  16 in total

1.  Association of MMP-2 expression and prognosis in osteosarcoma patients.

Authors:  Miao Zhang; Xuran Zhang
Journal:  Int J Clin Exp Pathol       Date:  2015-11-01

2.  Cyr61 silencing reduces vascularization and dissemination of osteosarcoma tumors.

Authors:  N Habel; M Vilalta; O Bawa; P Opolon; J Blanco; O Fromigué
Journal:  Oncogene       Date:  2014-07-28       Impact factor: 9.867

3.  Characterization of human multicentric osteosarcoma using newly established cells derived from multicentric osteosarcoma.

Authors:  Y Yamamoto; N Yamamoto; K Tajima; A Ohno; Y Washimi; D Ishimura; O Washimi; H Yamada
Journal:  J Cancer Res Clin Oncol       Date:  2010-05-04       Impact factor: 4.553

4.  Expression of matrix metalloproteinase-9 correlates with poor prognosis in human malignant fibrous histiocytoma.

Authors:  Jinyoung Yoo; Ji Han Jung; Seok Jin Kang; Chang Suk Kang
Journal:  Cancer Res Treat       Date:  2004-12-31       Impact factor: 4.679

5.  Antitumor activity of natural compounds, curcumin and PKF118-310, as Wnt/β-catenin antagonists against human osteosarcoma cells.

Authors:  Pay-Chin Leow; Quan Tian; Zhan-Yuin Ong; Zheng Yang; Pui-Lai Rachel Ee
Journal:  Invest New Drugs       Date:  2010-12       Impact factor: 3.850

6.  Wnt inhibitory factor 1 decreases tumorigenesis and metastasis in osteosarcoma.

Authors:  Elyssa M Rubin; Yi Guo; Khoa Tu; Jun Xie; Xiaolin Zi; Bang H Hoang
Journal:  Mol Cancer Ther       Date:  2010-03-02       Impact factor: 6.261

7.  Comments on Li H et al. "A systematic review of matrix metalloproteinase 9 as a biomarker of survival in patients with osteosarcoma".

Authors:  Qingyu Zhang; Jianmin Li; Fanxiao Liu; Zhenfeng Li
Journal:  Tumour Biol       Date:  2014-11-22

Review 8.  A systematic review of matrix metalloproteinase 9 as a biomarker of survival in patients with osteosarcoma.

Authors:  Hui Li; Kun Zhang; Li-hong Liu; Yurong Ouyang; Jie Bu; Hong-bin Guo; Tao Xiao
Journal:  Tumour Biol       Date:  2014-02-28

Review 9.  A review of clinical and molecular prognostic factors in osteosarcoma.

Authors:  Jonathan C M Clark; Crispin R Dass; Peter F M Choong
Journal:  J Cancer Res Clin Oncol       Date:  2007-10-27       Impact factor: 4.553

10.  Cyclooxygenase-2 overexpression predicts poor survival in patients with high-grade extremity osteosarcoma: a pilot study.

Authors:  Hiroshi Urakawa; Yoshihiro Nishida; Takahiro Naruse; Hiroatsu Nakashima; Naoki Ishiguro
Journal:  Clin Orthop Relat Res       Date:  2009-03-27       Impact factor: 4.176

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.